Andrew Gilchrist appointed as non-executive director at PLC

Feb.09.2023
Andrew Gilchrist appointed as non-executive director at PLC
Andrew Gilchrist appointed as non-executive director of Imperial Brands, effective from March 1st, 2023.

On February 7th, Imperial Tobacco (PLC) announced that Andrew Gilchrist will join the PLC Board of Directors as a non-executive director, effective from March 1st, 2023.


Andrew previously served as the Chief Financial Officer of Renault USA until it was acquired by British American Tobacco (BAT) in 2017. He has over 20 years of operations and financial experience in the tobacco industry. At Renault, Andrew held a series of leadership positions, including Chief Information Officer, Chief Business Officer, and Business Development Director. Early in his career, he worked in marketing and planning roles at BAT.


Chair Thérèse Esperdy said, "I am pleased to welcome Andrew to the board. In addition to his combined expertise in business and finance in our industry, he also has a strong track record in business development, strategic planning, and business integration. These skills, along with our continued transformation of Imperial Brands, will further enhance the efficiency of the board.


From March 1, 2023, Andrew will also join the Audit Committee and the Personnel and Governance Committee.


Reference(s):


【1】Appointment to the Board of Directors.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Turkey Plans to Ban E-Cigarette Advertising Under Revised Commercial Advertising Rules
Turkey Plans to Ban E-Cigarette Advertising Under Revised Commercial Advertising Rules
Turkey is advancing amendments to its Regulation on Commercial Advertising and Unfair Commercial Practices, proposing stricter controls on e-cigarette and gambling advertising.
Dec.26 by 2FIRSTS.ai
BAT Japan to launch two new VELO nicotine pouch flavours in February
BAT Japan to launch two new VELO nicotine pouch flavours in February
BAT Japan will roll out two new VELO nicotine pouch variants from Feb. 2, 2026: Smooth Peppermint Medium and Breezy Mango Intense. The products will be sold via the official glo & VELO online store, the glo Store Ginza and nationwide tobacco retail channels in Japan.
Jan.23 by 2FIRSTS.ai
Product | UWELL Launches CALIBURN BAR 80K Disposable Vape, Rated for 80,000 Puffs with 6 Power Levels and 3 Airflow Settings
Product | UWELL Launches CALIBURN BAR 80K Disposable Vape, Rated for 80,000 Puffs with 6 Power Levels and 3 Airflow Settings
UWELL has launched the CALIBURN BAR 80K disposable vape on its official website. The device features a staggering 80,000-puff count and a 20 mg/ml nicotine concentration. It offers two output modes (NORMAL and BOOST) with six adjustable power levels ranging from 18W to 35W, complemented by a 3-level airflow adjustment system.
Jan.14 by 2FIRSTS.ai
Imperial Brands Forms Global AI Partnership with Capgemini, Reinforcing Artificial Intelligence as Core Infrastructure in the Nicotine Industry
Imperial Brands Forms Global AI Partnership with Capgemini, Reinforcing Artificial Intelligence as Core Infrastructure in the Nicotine Industry
Industry Insight
Feb.19
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11
Six Years of Data Show FDA Clearing PMTA Backlog
Six Years of Data Show FDA Clearing PMTA Backlog
FDA data from FY2020 to FY2025 show how the PMTA system for e-cigarette products evolved after an early surge of submissions created prolonged front-end delays. Millions of applications accumulated at the Acceptance stage before entering substantive review. Since 2023, the number of applications pending acceptance has declined sharply, and industry participants report shorter initial decision timelines in late 2025.
Feb.06